Which hedge funds own ADCT? ADC THERAPEUTICS SA, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in ADCT (ADC THERAPEUTICS SA) in their Q2 2026 13F filings, worth $10.0m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.0% of its book. 1 manager opened a new position this quarter: Brevan Howard Capital Management. 2 exited: Marshall Wace, Renaissance Technologies LLC.
5tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold ADCT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | Q2 2026 | 0.0% | $3.9m | 3,649,144 | 8% | added |
| Millennium Management | Q2 2026 | 0.0% | $3.1m | 2,899,535 | -7% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $2.2m | 2,053,316 | 414% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $39.5k | 36,885 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $769.7k | 719,320 | 196% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $170.5k |
| Renaissance Technologies LLC | 0.0% | $1.1m |
How has hedge fund ownership of ADCT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $10.0m |
| Q1 2026 | 6 | $28.1m |
| Q4 2025 | 1 | $17.7m |
| Q3 2025 | 1 | $32.5m |
| Q2 2025 | 2 | $23.1m |
| Q1 2025 | 1 | $1.1m |
| Q4 2024 | 1 | $3.8m |
| Q1 2023 | 1 | $279.6k |
| Q4 2022 | 1 | $2.7m |
| Q3 2022 | 3 | $572.0k |
| Q2 2022 | 3 | $905.0k |
| Q1 2022 | 1 | $2.0k |
| Q4 2021 | 1 | $4.0k |
| Q3 2021 | 1 | $5.0k |
| Q2 2021 | 1 | $4.0k |
| Q1 2021 | 1 | $4.0k |
Counts every tracked manager that disclosed ADCT in that quarter's filing, including managers that have since stopped filing.